专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07019028B2 Endiandric acid H and its derivatives, process for their preparation and use thereof 失效
标题翻译：内切酸H及其衍生物，其制备及使用方法
公开(公告)号：US07019028B2
公开(公告)日：2006-03-28
申请号：US10627850
申请日：2003-07-25
申请人： Claudia Eder , Herbert Kogler , Sabine Haag-Richter
发明人： Claudia Eder , Herbert Kogler , Sabine Haag-Richter
IPC分类号： A61K31/36 , C07D317/44
CPC分类号： C07D317/60
摘要： The invention relates to compounds of the formula (I) process for their preparation starting from the plant Beilschmiedia fulva, PLA 101037, and the use thereof for producing a medicament, in particular for the treatment of allergic disorders, of asthmatic disorders, of inflammatory concomitant symptoms of asthma and/or of diseases which can be treated by inhibiting c-maf and NFAT.
摘要翻译：本发明涉及从植物Beilschmiedia fulva，PLA 101037开始制备的式（I）化合物及其用于制备药物，特别是用于治疗过敏性疾病的哮喘性疾病，炎性伴随症的药物可以通过抑制c-maf和NFAT治疗的哮喘和/或疾病的症状。

2. 发明授权

US06297043B1 Mumbaistatin, a process for it's production and its use as a pharmaceutical 失效
标题翻译：孟买斯他汀（Mumbaistatin），它是生产和作为药物使用的过程
公开(公告)号：US06297043B1
公开(公告)日：2001-10-02
申请号：US09338601
申请日：1999-06-23
申请人： Nirogi Venkata Satya Ramakrishna , Keshavapura Hosamane Sreedhara Swamy , Erra Koteswara Satya Vijaya Kumar , Manoj Maniram Singh Kushwaha , Sridevi Kota , Mythili Raman , Swati Dhananjay Tare , Sunil Kumar Deshmukh , Dietmar Schummer , Michael Kurz , Herbert Kogler
发明人： Nirogi Venkata Satya Ramakrishna , Keshavapura Hosamane Sreedhara Swamy , Erra Koteswara Satya Vijaya Kumar , Manoj Maniram Singh Kushwaha , Sridevi Kota , Mythili Raman , Swati Dhananjay Tare , Sunil Kumar Deshmukh , Dietmar Schummer , Michael Kurz , Herbert Kogler
IPC分类号： C12N100
CPC分类号： C12R1/465 , C12P1/04 , Y10S435/822 , Y10S435/886
摘要： The present invention relates to a compound named Mumbaistatin, its pharmaceutically acceptable salts and derivatives, a process for its production, and its use as a pharmaceutical. Mumbaistatin is obtainable by cultivation of the microorganism HIL-008003 (DSM 11641). Mumbaistatin is a glucose-6-phosphate translocase inhibitor and can be used in the treatment of diabetes mellitus. The present invention further relates to a process for the production of Mumbaistatin, to the microorganism HIL-008003 (DSM 11641), to the use of Mumbaistatin and its pharmaceutically acceptable salts and derivatives as pharmaceuticals, in particular to their use in the treatment of diabetes mellitus, and to pharmaceutical compositions comprising Mumbaistatin or a pharmaceutically acceptable salt or derivative thereof.
摘要翻译：本发明涉及一种名为孟巴斯丁（Mumbaistatin）的化合物及其药学上可接受的盐和衍生物，其生产方法及其作为药物的用途。孟巴斯汀可通过培养微生物HIL-008003（DSM 11641）获得。孟巴司他是一种葡萄糖-6-磷酸转位酶抑制剂，可用于治疗糖尿病。本发明还涉及生产孟鲁司他汀对微生物HIL-008003（DSM11641）的使用，以使用孟巴斯妥及其药学上可接受的盐和衍生物作为药物，特别是其用于治疗糖尿病以及包含孟巴斯妥坦或其药学上可接受的盐或衍生物的药物组合物。

3. 发明授权

US5571701A Antibiotic, balhimycin, a process for its production and its use as pharmaceutical 失效
标题翻译：抗生素，巴利霉素，其生产过程及其用作药物
公开(公告)号：US5571701A
公开(公告)日：1996-11-05
申请号：US449543
申请日：1995-05-24
申请人： Suresh R. Nadkarni , Sugata Chatterjee , Mahesh V. Patel , Kalvanapuram R. Desikan , Erra K. S. Vijayakumar , Bimal N. Ganguli , Jurgen Blumbach , Hans-Wolfram Fehlhaber , Herbert Kogler
发明人： Suresh R. Nadkarni , Sugata Chatterjee , Mahesh V. Patel , Kalvanapuram R. Desikan , Erra K. S. Vijayakumar , Bimal N. Ganguli , Jurgen Blumbach , Hans-Wolfram Fehlhaber , Herbert Kogler
IPC分类号： A61K38/00 , C07K4/04 , C12P1/06 , C12P21/04 , C12N1/20 , C07K9/00 , A61K38/14
CPC分类号： C07K9/008 , C12P1/06 , A61K38/00 , Y10S930/19
摘要： Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 C1.sub.2 N.sub.9 0.sub.24, is a novel Glycopeptide antibiotic and has the following structure: ##STR1##
摘要翻译：分子式C66H73C12N9024的化合物Balhimycin是一种新型的糖肽抗生素，具有以下结构：

4. 发明授权

US5451570A Antibiotic, balhimycin, a process for its production and its use as pharmaceutical 失效
标题翻译：抗生素，巴利霉素，其生产过程及其用作药物
公开(公告)号：US5451570A
公开(公告)日：1995-09-19
申请号：US996936
申请日：1992-12-30
申请人： Suresh R. Nadkarni , Sugata Chatterjee , Mahesh V. Patel , Kalvanapuram R. Desikan , Erra K. S. Vijayakumar , Bimal N. Ganguli , Jurgen Blumbach , Hans-Wolfram Fehlhaber , Herbert Kogler
发明人： Suresh R. Nadkarni , Sugata Chatterjee , Mahesh V. Patel , Kalvanapuram R. Desikan , Erra K. S. Vijayakumar , Bimal N. Ganguli , Jurgen Blumbach , Hans-Wolfram Fehlhaber , Herbert Kogler
IPC分类号： A61K38/00 , C07K4/04 , C12P1/06 , A61K38/14 , A61K38/12 , C07K9/00
CPC分类号： C07K9/008 , C12P1/06 , A61K38/00 , Y10S930/19
摘要： Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 Cl.sub.2 N.sub.9 O.sub.24, is a novel Glycopeptide antibiotic and has the following structure (SEQ. ID. No. 1): ##STR1##
摘要翻译：分子式为C66H73Cl2N9O24的化合物巴尔霉素是新型的糖肽抗生素，具有以下结构（SEQ ID NO：1）：

5. 发明授权

US06933298B2 Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases 有权
标题翻译：吡啶-2,4-二羧酸二酰胺和嘧啶-4,6-二羧酸二酰胺及其用于选择性抑制胶原酶的用途
公开(公告)号：US06933298B2
公开(公告)日：2005-08-23
申请号：US10065994
申请日：2002-12-09
申请人： Klaus-Ulrich Weithmann , Jörg Habermann , Herbert Kogler , Reinhard Kirsch , Volkmar Wehner
发明人： Klaus-Ulrich Weithmann , Jörg Habermann , Herbert Kogler , Reinhard Kirsch , Volkmar Wehner
IPC分类号： C07D213/81 , C07D239/28 , C07D405/12 , C07D405/14 , C07D239/26 , A61K31/506 , A61P35/00 , C07D403/12 , C07D403/14
CPC分类号： C07D213/81 , C07D239/28 , C07D405/12 , C07D405/14
摘要： Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides of formula I. These compounds are found to possess the property of selectively inhibiting collagenase (MMP). They may therefore be useful in prophylaxis and therapy of diseases whose course involves an increased activity of matrix metalloproteinase 13.
摘要翻译：吡啶-2,4-二羧酸二酰胺和式I的嘧啶-4,6-二羧酸二酰胺。发现这些化合物具有选择性抑制胶原酶（MMP）的性质。因此，它们可用于预防和治疗其课程涉及基质金属蛋白酶13活性增加的疾病。

6. 发明授权

US6022851A Lantibiotic related to actagardine, and processes for the preparation and use thereof 有权
标题翻译：与阿达加丁有关的蓝霉素，以及其制备和使用的方法
公开(公告)号：US6022851A
公开(公告)日：2000-02-08
申请号：US172042
申请日：1998-10-14
申请人： Laszlo Vertesy , Herbert Kogler , Matthias Schiell , Joachim Wink
发明人： Laszlo Vertesy , Herbert Kogler , Matthias Schiell , Joachim Wink
IPC分类号： C12P21/02 , A61K31/00 , A61K38/00 , A61P31/00 , A61P31/04 , C07K7/08 , C07K14/365 , C12R1/045 , A61K38/04 , A61K38/12 , C07K1/107 , C07K4/04
CPC分类号： C07K7/08 , A61K38/00
摘要： The present invention relates to a novel lantibiotic having the formula NH.sub.2 --R-actagardine, where NH.sub.2 --R is the radical of the amino acid alanine, which is formed by the microorganism Actinoplanes liguriae, DSM 11797 or Actinoplanes garbadiensis, DSM 11796 during fermentation, chemical derivatives of the lantibiotic, a process for its preparation and the use of the lantibiotics as pharmaceuticals.
摘要翻译：本发明涉及一种新型的具有式NH2-R-卡那加丁的羊毛硫抗生素，其中NH2-R是氨基酸丙氨酸的基团，其由微生物活性荧光素，DSM 11797或Actinoplanes garbadiensis，DSM 11796在发酵过程中形成，羊毛硫抗生素的化学衍生物，其制备方法以及作为药物使用的羊毛硫抗生素。

7. 发明授权

US5112858A Antibiotic, aranorosin, a microbiological process for the preparation thereof, and the use thereof as a pharmaceutical 失效
标题翻译：抗生素，阿那曲宁，其制备的微生物过程及其作为药物的用途
公开(公告)号：US5112858A
公开(公告)日：1992-05-12
申请号：US350288
申请日：1989-05-11
申请人： Kirity Roy , Triptikumar Mukhopadhyay , Goukanapalli C. S. Reddy , Erra K. S. Vijayakumar , Bimal N. Ganguli , Richard H. Rupp , Hans-Wolfram Fehlhaber , Herbert Kogler
发明人： Kirity Roy , Triptikumar Mukhopadhyay , Goukanapalli C. S. Reddy , Erra K. S. Vijayakumar , Bimal N. Ganguli , Richard H. Rupp , Hans-Wolfram Fehlhaber , Herbert Kogler
IPC分类号： A61K31/34 , A61P31/04 , A61P35/00 , C07D493/20 , C12N1/14 , C12P17/18 , C12R1/645
CPC分类号： C07D493/20 , C12P17/181 , C12R1/01
摘要： A new antibiotic, aranorosin, a microbiological process for the preparation thereof, and the use thereof as a pharmaceutical.Aranorosin, a compound of the formula ##STR1## can be prepared with the aid of the fungus culture Y-30499 (DSM 4151). Aranorosin has an antibiotic action as well as an action against malignant tumors.
摘要翻译：一种新的抗生素，aranorosin，其制备的微生物过程及其作为药物的用途。可以借助于真菌培养物Y-30499（DSM 4151）来制备阿曲诺星，式的化合物。 Aranorosin具有抗生素作用以及抗恶性肿瘤的作用。

8. 发明授权

US06818667B2 Eurotinones, and derivatives thereof, processes for preparing them, and their use 有权
标题翻译：欧卡因及其衍生物，其制备方法及其应用
公开(公告)号：US06818667B2
公开(公告)日：2004-11-16
申请号：US10180003
申请日：2002-06-26
申请人： Claudia Eder , Herbert Kogler , Luigi Toti
发明人： Claudia Eder , Herbert Kogler , Luigi Toti
IPC分类号： A61K31335
CPC分类号： C07D313/12
摘要： The present invention relates to novel compounds of the formula I in which R(1), R(2), R(3) and R(4) are, independently of each other, hydrogen or an alkyl radical. The compounds of the formula I are inhibitors of KDR kinase and, due to their antiangiogenic effect, are suitable for preventing and/or treating malignant diseases. The compounds of the formula I can be obtained by fermenting the microorganism Eurotium echinulatum Delacroix (DSM 13872) or by chemically derivatizing the compounds which are obtained after fermenting said microorganism. The invention consequently also relates to a process for preparing the compounds of the formula I, to the use of the compounds of the formula I for preparing a pharmaceutical for treating malignant diseases and diseases which can be treated by inhibiting KDR kinase, and also to pharmaceutical preparations which have a content of at least one compound of the formula I.
摘要翻译：本发明涉及式Iin的新化合物，其中R（1），R（2），R（3）和R（4）彼此独立地为氢或烷基。式I的化合物是KDR激酶的抑制剂，并且由于其抗血管生成作用，适用于预防和/或治疗恶性疾病。式I的化合物可以通过发酵微生物欧氏螺旋体（DSM 13872）或通过化学衍生在发酵所述微生物后获得的化合物而获得。因此，本发明还涉及制备式I化合物的方法，使用式I化合物来制备治疗可通过抑制KDR激酶治疗的恶性疾病和疾病的药物，还涉及药物具有至少一种式I化合物含量的制剂。

9. 发明授权

US06627604B2 Memno peptides, process for their preparation and use thereof 有权
标题翻译： Memno肽，其制备方法和用途
公开(公告)号：US06627604B2
公开(公告)日：2003-09-30
申请号：US09794346
申请日：2001-02-28
申请人： Laszlo Vertesy , Herbert Kogler , Astrid Markus , Matthias Schiell
发明人： Laszlo Vertesy , Herbert Kogler , Astrid Markus , Matthias Schiell
IPC分类号： A61K3808
CPC分类号： C07K7/06 , A61K38/00
摘要： The invention relates to novel peptide derivatives, called memno peptides, of the formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8 and (A)n have the meaning herein, obtainable by cultivation of Memnoniella echinata FH2272, DSM 13195 or mutants and variants of this, a process for their preparation and the use of the compounds as pharmaceuticals, for example against cardiac insufficiency.
摘要翻译：本发明涉及式（I）所示的新型肽衍生物（称为memno肽）：其中R1，R2，R3，R4，R5，R6，R7，R8和（A）n具有本文的含义，可通过培养Memnoniella echinata FH2272，DSM 13195或其突变体和变体，其制备方法和化合物用作药物的方法，例如针对心脏功能不全。

10. 发明授权

US06221844B1 Antifungal peptides from scleroderma texense 失效
标题翻译：来自硬皮病texense的抗真菌肽
公开(公告)号：US06221844B1
公开(公告)日：2001-04-24
申请号：US09155603
申请日：1999-05-18
申请人： Heike Stump , Wilhelm Stahl , Joachim Wink , Astrid Markus , Herbert Kogler , Jürgen Backhaus
发明人： Heike Stump , Wilhelm Stahl , Joachim Wink , Astrid Markus , Herbert Kogler , Jürgen Backhaus
IPC分类号： A61K3800
CPC分类号： C07K7/02 , A61K38/00
摘要： The invention relates to novel peptides, namely texenomycins, from Scleroderma texense, a process for their preparation and their use as pharmaceuticals, in particular as antimycotics. The texenomycins according to the present invention are distinguished in particular by the amino acid sequence I in which FS is an oxo fatty acid radical, Aib is aminoisobutyric acid and Arg-ol=argininol.
摘要翻译：本发明涉及来自硬皮病texense的新型肽，即泰克星菌素，其制备方法及其作为药物，特别是抗真菌剂的用途。根据本发明的泰克星霉素特别是由以下的氨基酸序列Iin区分：其中FS是氧代脂肪酸基，Aib是氨基异丁酸，Ar-ol =精氨醇。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式